TipRanks
Advertisement
Advertisement
Draig Therapeutics Highlights Phase 1 Data for DT-101 at Clinical Meeting
PremiumPrivate CompaniesDraig Therapeutics Highlights Phase 1 Data for DT-101 at Clinical Meeting
4M ago
Draig Therapeutics CEO Featured at U.K. Life Sciences Summit Highlighting Ecosystem Collaboration
Premium
Private Companies
Draig Therapeutics CEO Featured at U.K. Life Sciences Summit Highlighting Ecosystem Collaboration
5M ago
Draig Therapeutics CEO Featured at U.K. Life Sciences Summit Amid Sector Headwinds
Premium
Private Companies
Draig Therapeutics CEO Featured at U.K. Life Sciences Summit Amid Sector Headwinds
5M ago
Draig Therapeutics to Present Phase 1 Data on DT-101 at Key Psychopharmacology Meeting
PremiumPrivate CompaniesDraig Therapeutics to Present Phase 1 Data on DT-101 at Key Psychopharmacology Meeting
5M ago
Draig Therapeutics Previews Phase 1 DT-101 Data at Major Psychopharmacology Meeting
Premium
Private Companies
Draig Therapeutics Previews Phase 1 DT-101 Data at Major Psychopharmacology Meeting
5M ago
Draig Therapeutics Highlights Executive Visibility With Convergence Forum C-Suite Participation
Premium
Private Companies
Draig Therapeutics Highlights Executive Visibility With Convergence Forum C-Suite Participation
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―